Tetratherix
Alexandria
About Tetratherix
Tetratherix is a biomedical company specializing in the development of innovative medical devices aimed at enhancing regenerative medicine. Its flagship product, the first biostealth fluid matrix, represents a breakthrough in the field, offering new possibilities for tissue regeneration and targeted mRNA delivery. The company's technology focuses on bonding agents that promote healing, addressing a wide range of medical conditions. With a commitment to advancing healthcare through science, Tetratherix's solutions are designed to improve patient outcomes by harnessing the body's own regenerative capabilities.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $2.1M
- Funding stage: IPO
- Last round: Grant (Jul 2025)
- Ticker: asx:TTX
- Website: tetratherix.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Clinical Trials, Medical Device, Precision Medicine
Social Profiles
Canonical: https://fsome.com/organization/tetratherix-16328 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.